TRVITrevi Therapeutics, Inc.
$12.61+19% 1Y
$12.61
$9.9952 weeks$19.49
Is the business good?
How good a business is TRVI?
- Share count, year on year
- +20%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Free cash flow, trailing twelve months
- −$53M
- Net income, trailing twelve months
- −$51M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screens:Most shorted stocks